New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission

BACKGROUND: An effective malaria transmission-blocking vaccine (TBV) would be a major advance in the current efforts to eliminate and, ultimately, eradicate malaria. Antibodies against Plasmodium falciparum surface protein, Pfs25, are known to block parasite development in the mosquito vector. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: McGuire, Kathleen A., Miura, Kazutoyo, Wiethoff, Christopher M., Williamson, Kim C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471885/
https://www.ncbi.nlm.nih.gov/pubmed/28619071
http://dx.doi.org/10.1186/s12936-017-1896-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471885/
https://www.ncbi.nlm.nih.gov/pubmed/28619071
http://dx.doi.org/10.1186/s12936-017-1896-7

Ejemplares similares